500 Emerging Europe — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Massive Biomassivebio.com𝕏Apr 2019
Massive Bio operates an AI-based platform that matches cancer patients with oncology clinical trials and provides concierge support throughout the trial process.
AI & Machine LearningBiotechDigital HealthHealthtechNew York, US
Selin Kurnaz(Executive Officer)inArturo Loaiza-Bonilla(Director)in
Co-investorsRevo Capitale2vc
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.